Institutions own 25% of ProQR Therapeutics N.V. (NASDAQ:PRQR) shares but retail investors control 46% of the company

By Yahoo! Finance | Jun 23, 2024 at 10:51 AM EST

14 investors collectively own 50% of ProQR Therapeutics, with retail investors holding 46%, institutions 25%, and hedge funds a small stake. The largest shareholder is Eli Lilly with 16%, while the CEO owns 0.9%. No single shareholder has a majority stake.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.